• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Projects led by Pitt chemical engineers receive more than $1 million in NSF funding

Bioengineer by Bioengineer
September 17, 2020
in Science News
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: University of Pittsburgh

Two projects led by professors in the Department of Chemical and Petroleum Engineering at the University of Pittsburgh’s Swanson School of Engineering have recently received funding from the National Science Foundation.

Lei Li, associate professor of chemical and petroleum engineering at Pitt, is leading a project that will investigate the water wettability of floating graphene. Research over the past decade by Li and others has shown that water has the ability to “see through” atomic-thick layers of graphene, contributing to the “wetting transparency” effect.

“This finding provides a unique opportunity for designing multi-functional devices, since it means that the wettability of an atomic-thick film can be tuned by selecting an appropriate supporting substrate,” said Li. “Because the substrate is liquid, one can control the wettability in real-time, a capability that would be very useful for water harvesting of moisture from the air and in droplet microfluidics devices.”

The current project will use both experimental and computational methods to understand the mechanisms of wetting transparency of graphene on liquid substrates and demonstrate the real-time control of surface wettability. Li and his co-PIs Kenneth Jordan, Richard King Mellon Professor and Distinguished Professor of Computational Chemistry at Pitt and co-director of the Center for Simulation and Modeling; and Haitao Liu, professor of chemistry at Pitt, received $480,000 for the project titled, “Water wettability of floating graphene: Mechanism and Application.”

The second project will develop technology to help enable the widespread adoption of renewable energy, like solar and wind power. James McKone, assistant professor of chemical and petroleum engineering at Pitt, is collaborating with researchers at the University of Rochester and the University at Buffalo to develop a new generation of high-performance materials for liquid-phase energy storage systems like redox flow batteries, one of McKone’s areas of expertise. The project, “Collaborative Research: Designing Soluble Inorganic Nanomaterials for Flowable Energy Storage,” received $598,000 from the National Science Foundation, with $275,398 designated for Pitt.

McKone’s team will investigate the molecular properties of soluble, earth-abundant nanomaterials for use in liquid-phase battery systems. These batteries are designed to store massive amounts of electricity from renewable energy sources and provide steady power to the grid.

“Unlike the batteries we normally think of in phones and laptop computers, this technology uses liquid components that are low-cost, safe and long-lasting,” said McKone. “With continued development, this will make it possible to store all of the new wind and solar power that is coming available on the electric grid without adding a significant additional cost.”

###

McKone is collaborating with Dr. Ellen Matson, Wilmot Assistant Professor of Chemistry at the University of Rochester, and Dr. Timothy Cook, Associate Professor of Chemistry at the University at Buffalo.

Media Contact
Maggie Pavlick
[email protected]

Original Source

https://www.engineering.pitt.edu/News/2020/ChemE-NSF-Funding/

Tags: Chemistry/Physics/Materials SciencesEnergy SourcesIndustrial Engineering/Chemistry
Share12Tweet8Share2ShareShareShare2

Related Posts

Zidesamtinib Demonstrates Lasting Efficacy in ROS1 TKI-Pretreated NSCLC, Including Cases with CNS Involvement and ROS1 G2032R Mutations

September 7, 2025

Crizotinib Does Not Enhance Disease-Free Survival in Resected Early-Stage ALK-Positive NSCLC

September 7, 2025

FLAURA2 Trial Demonstrates Enhanced Overall Survival with Osimertinib and Chemotherapy in EGFR-Mutated Advanced NSCLC

September 7, 2025

Ivonescimab Combined with Chemotherapy Enhances Progression-Free Survival in EGFR-Positive NSCLC Patients After Third-Generation EGFR-TKI Treatment

September 7, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    55 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Zidesamtinib Demonstrates Lasting Efficacy in ROS1 TKI-Pretreated NSCLC, Including Cases with CNS Involvement and ROS1 G2032R Mutations

Crizotinib Does Not Enhance Disease-Free Survival in Resected Early-Stage ALK-Positive NSCLC

FLAURA2 Trial Demonstrates Enhanced Overall Survival with Osimertinib and Chemotherapy in EGFR-Mutated Advanced NSCLC

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.